Non-additive effects between genetic CETP and SGLT2 inhibition on diabetes risk are not detected, as the interaction term is not significantly associated with diabetes risk (Estimate: -0.00233; 95% CI: -0.008 to 0.004; p-value=0.454) (Supplementary 7). The gene discussed is SLC5A2; the disease is diabetes mellitus.